Empresas.- Llega a España 'Altuvoct' (efanesoct...
European Commission Grants Sobi® Marketing Auth...
Sobi scores EU approval for haemophilia A repla...
Altuvoct® – Schutz und Lebensqualität für Patie...
Bestellen Sie hier Ihr Haemo Pack™!
Sobi FM Secures Accreditation as Only Nigerian ...
Sobi receives NICE recommendation for Altuvoct ...
Sobi: Η βιοφαρμακευτική εταιρεία σημειώνει συνε...
Explore children’s challenges
Altopack Best Packaging 2020 POR - YouTube
Sobi’s Altuvoct gains approval from MHRA | The ...
Sobi Med - AltuvOct - Adult
SOBI - Altuvoct And Beyfortus Launches Will Ope...
American Hospital & Healthcare Management - Ame...
Sobi gets EU okay for long-acting haemophilia A...
Altuvoct® de Sobi ya está disponible en España ...
How can we protect children from future complic...
«Κόκκινη Κλωστή»: Ολοκληρώνεται η ενημερωτική ε...
European Commission grants Sobi Marketing Autho...
Sobi announces commercial launch of Elocta® in ...
NICE recommends Sobi’s Altuvoct for severe hemo...
Sobi | EUCOPE AISBL
EC approves Sobi’s Altuvoct for hemophilia A | ...
Sobi’s Altuvoct Receives the EC’s Marketing Aut...
Bánh Cracker & chocolate Sobi original - Anko V...
Dutohlávka sobí | 4health.cz
NEJM Publishes Phase 3 Results of ALTUVOCT® XTE...
Prophylaxis is not sufficient to prevent joint ...
'Altuvoct', de Sobi, aprobado por la CE para el...
Explore adults’ challenges